VELA Investment Management LLC Takes $2.17 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

VELA Investment Management LLC acquired a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 80,120 shares of the medical instruments supplier's stock, valued at approximately $2,168,000.

A number of other large investors have also bought and sold shares of the stock. First Eagle Investment Management LLC grew its position in shares of DENTSPLY SIRONA by 33.6% during the second quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier's stock worth $325,571,000 after purchasing an additional 3,283,965 shares in the last quarter. SG Americas Securities LLC lifted its holdings in shares of DENTSPLY SIRONA by 2,959.1% in the 1st quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier's stock valued at $45,584,000 after buying an additional 1,328,525 shares during the period. Dimensional Fund Advisors LP raised its holdings in DENTSPLY SIRONA by 42.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier's stock worth $110,118,000 after purchasing an additional 1,308,411 shares during the period. Cooke & Bieler LP increased its stake in DENTSPLY SIRONA by 16.2% during the 2nd quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier's stock worth $186,996,000 after buying an additional 1,046,105 shares in the last quarter. Finally, Edmond DE Rothschild Holding S.A. grew its position in shares of DENTSPLY SIRONA by 398.2% in the first quarter. Edmond DE Rothschild Holding S.A. now owns 1,025,200 shares of the medical instruments supplier's stock valued at $34,026,000 after purchasing an additional 819,400 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Price Performance

Shares of XRAY traded up $0.32 during trading hours on Friday, reaching $23.49. 2,328,568 shares of the stock traded hands, compared to its average volume of 2,225,088. The company's 50-day moving average price is $25.08 and its two-hundred day moving average price is $26.22. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. The company has a market cap of $4.76 billion, a P/E ratio of -27.31, a price-to-earnings-growth ratio of 1.26 and a beta of 1.02. DENTSPLY SIRONA Inc. has a 52-week low of $22.85 and a 52-week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing analysts' consensus estimates of $0.50 by ($0.01). The firm had revenue of $984.00 million for the quarter, compared to analysts' expectations of $993.61 million. DENTSPLY SIRONA had a negative net margin of 4.75% and a positive return on equity of 11.86%. The company's revenue was down 4.3% on a year-over-year basis. During the same period in the previous year, the company earned $0.51 EPS. On average, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several recent analyst reports. Stifel Nicolaus dropped their target price on DENTSPLY SIRONA from $30.00 to $28.00 and set a "hold" rating on the stock in a report on Thursday, July 18th. StockNews.com upgraded DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a report on Monday, October 28th. Needham & Company LLC decreased their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a "buy" rating for the company in a research report on Friday, October 25th. Evercore ISI cut their target price on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an "outperform" rating on the stock in a report on Tuesday, October 8th. Finally, Barrington Research reaffirmed an "outperform" rating and issued a $36.00 price target on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Four equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $32.67.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.